ERBB2 and breast cancer: Among 319 HR-negative/HER2-negative BC patients, 96 cases (30.1%) experienced recurrence or metastasis, of which distant metastasis included, 31 bone metastasis, 16 lung metastasis, 15 liver metastasis, and 8 brain metastasis.